Tag : RNAi Therapeutics

Digital Health, Technology & Innovation

Arrowhead Starts Phase 1/2a Study of ARO-DIMER-PA

Business Wire
by Business Wire037
– ARO-DIMER-PA is the first clinical candidate designed to silence the expression of two genes with a single RNAi molecule – In preclinical studies, ARO-DIMER-PA...